Jason Fung The Obesity Code Schedule a consultation with Celeste or Dr
In the U.S., GLP-1 prescriptions more than doubled in just 18 months, topping nine million by early 2024
Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
Type 2 diabetes susceptibility gene TCF7L2 and its role in -cell function
No medical, therapeutic, or diagnostic claims are made or implied
Study Duration: 20-64 weeks